nodes	percent_of_prediction	percent_of_DWPC	metapath
Esmolol—Ibuprofen—Melphalan—breast cancer	0.597	1	CrCrCtD
Esmolol—Chlorphenesin—CYP19A1—breast cancer	0.000635	0.0783	CrCbGaD
Esmolol—Chlorphenesin—BCHE—breast cancer	0.000634	0.0782	CrCbGaD
Esmolol—Ibuprofen—BCL2—breast cancer	0.000557	0.0687	CrCbGaD
Esmolol—Ibuprofen—ABCC1—breast cancer	0.000505	0.0623	CrCbGaD
Esmolol—Ibuprofen—CXCL8—breast cancer	0.000447	0.0551	CrCbGaD
Esmolol—Betaxolol—CYP2D6—breast cancer	0.000351	0.0433	CrCbGaD
Esmolol—Bisoprolol—CYP2D6—breast cancer	0.000339	0.0418	CrCbGaD
Esmolol—Acebutolol—CYP2D6—breast cancer	0.000321	0.0396	CrCbGaD
Esmolol—Oxprenolol—CYP2D6—breast cancer	0.000319	0.0393	CrCbGaD
Esmolol—Chlorphenesin—CYP3A4—breast cancer	0.000298	0.0368	CrCbGaD
Esmolol—Chlorphenesin—PTGS2—breast cancer	0.000292	0.036	CrCbGaD
Esmolol—Alprenolol—CYP2D6—breast cancer	0.000292	0.0359	CrCbGaD
Esmolol—Bisoprolol—CYP3A4—breast cancer	0.000291	0.0359	CrCbGaD
Esmolol—Metoprolol—CYP2D6—breast cancer	0.000271	0.0334	CrCbGaD
Esmolol—Pindolol—CYP2D6—breast cancer	0.000251	0.0309	CrCbGaD
Esmolol—Atenolol—ABCB1—breast cancer	0.000248	0.0306	CrCbGaD
Esmolol—Acebutolol—ABCB1—breast cancer	0.000229	0.0283	CrCbGaD
Esmolol—Ibuprofen—PTGS1—breast cancer	0.000228	0.0281	CrCbGaD
Esmolol—Propafenone—CYP2D6—breast cancer	0.0002	0.0246	CrCbGaD
Esmolol—Metoprolol—ABCB1—breast cancer	0.000194	0.0239	CrCbGaD
Esmolol—Propranolol—CYP1A1—breast cancer	0.000184	0.0227	CrCbGaD
Esmolol—Propafenone—CYP3A4—breast cancer	0.000171	0.0211	CrCbGaD
Esmolol—Hyperhidrosis—Paclitaxel—breast cancer	0.00015	0.000402	CcSEcCtD
Esmolol—Nasopharyngitis—Doxorubicin—breast cancer	0.00015	0.0004	CcSEcCtD
Esmolol—Drowsiness—Methotrexate—breast cancer	0.000149	0.000398	CcSEcCtD
Esmolol—Anorexia—Paclitaxel—breast cancer	0.000148	0.000396	CcSEcCtD
Esmolol—Vomiting—Vinorelbine—breast cancer	0.000147	0.000393	CcSEcCtD
Esmolol—Body temperature increased—Gemcitabine—breast cancer	0.000147	0.000392	CcSEcCtD
Esmolol—Dysuria—Epirubicin—breast cancer	0.000146	0.000391	CcSEcCtD
Esmolol—Dizziness—Thiotepa—breast cancer	0.000146	0.00039	CcSEcCtD
Esmolol—Hypotension—Paclitaxel—breast cancer	0.000145	0.000388	CcSEcCtD
Esmolol—Urticaria—Fluorouracil—breast cancer	0.000145	0.000388	CcSEcCtD
Esmolol—Headache—Vinorelbine—breast cancer	0.000145	0.000387	CcSEcCtD
Esmolol—Syncope—Docetaxel—breast cancer	0.000145	0.000387	CcSEcCtD
Esmolol—Body temperature increased—Fluorouracil—breast cancer	0.000144	0.000386	CcSEcCtD
Esmolol—Propafenone—ABCB1—breast cancer	0.000143	0.0176	CrCbGaD
Esmolol—Loss of consciousness—Docetaxel—breast cancer	0.000142	0.000379	CcSEcCtD
Esmolol—Angina pectoris—Doxorubicin—breast cancer	0.000141	0.000376	CcSEcCtD
Esmolol—Vomiting—Thiotepa—breast cancer	0.00014	0.000375	CcSEcCtD
Esmolol—Syncope—Capecitabine—breast cancer	0.00014	0.000375	CcSEcCtD
Esmolol—Convulsion—Docetaxel—breast cancer	0.00014	0.000374	CcSEcCtD
Esmolol—Paraesthesia—Paclitaxel—breast cancer	0.00014	0.000373	CcSEcCtD
Esmolol—Drowsiness—Epirubicin—breast cancer	0.000139	0.000372	CcSEcCtD
Esmolol—Dyspnoea—Paclitaxel—breast cancer	0.000139	0.00037	CcSEcCtD
Esmolol—Headache—Thiotepa—breast cancer	0.000138	0.00037	CcSEcCtD
Esmolol—Somnolence—Paclitaxel—breast cancer	0.000138	0.000369	CcSEcCtD
Esmolol—Chest pain—Docetaxel—breast cancer	0.000138	0.000367	CcSEcCtD
Esmolol—Loss of consciousness—Capecitabine—breast cancer	0.000137	0.000367	CcSEcCtD
Esmolol—Nausea—Vinorelbine—breast cancer	0.000137	0.000367	CcSEcCtD
Esmolol—Dyspepsia—Paclitaxel—breast cancer	0.000137	0.000366	CcSEcCtD
Esmolol—Asthenia—Mitoxantrone—breast cancer	0.000137	0.000366	CcSEcCtD
Esmolol—Asthenia—Irinotecan—breast cancer	0.000137	0.000366	CcSEcCtD
Esmolol—Propranolol—CYP2D6—breast cancer	0.000137	0.0169	CrCbGaD
Esmolol—Neuropathy peripheral—Epirubicin—breast cancer	0.000137	0.000365	CcSEcCtD
Esmolol—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—breast cancer	0.000137	0.000365	CcSEcCtD
Esmolol—Dysuria—Doxorubicin—breast cancer	0.000135	0.000361	CcSEcCtD
Esmolol—Decreased appetite—Paclitaxel—breast cancer	0.000135	0.000361	CcSEcCtD
Esmolol—Dry mouth—Docetaxel—breast cancer	0.000135	0.000359	CcSEcCtD
Esmolol—Gastrointestinal disorder—Paclitaxel—breast cancer	0.000134	0.000359	CcSEcCtD
Esmolol—Fatigue—Paclitaxel—breast cancer	0.000134	0.000358	CcSEcCtD
Esmolol—Asthenia—Gemcitabine—breast cancer	0.000133	0.000356	CcSEcCtD
Esmolol—Chest pain—Capecitabine—breast cancer	0.000133	0.000356	CcSEcCtD
Esmolol—Constipation—Paclitaxel—breast cancer	0.000133	0.000355	CcSEcCtD
Esmolol—Pain—Paclitaxel—breast cancer	0.000133	0.000355	CcSEcCtD
Esmolol—Confusional state—Docetaxel—breast cancer	0.000133	0.000355	CcSEcCtD
Esmolol—Pharyngitis—Methotrexate—breast cancer	0.000133	0.000355	CcSEcCtD
Esmolol—Anxiety—Capecitabine—breast cancer	0.000133	0.000354	CcSEcCtD
Esmolol—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—breast cancer	0.000132	0.000353	CcSEcCtD
Esmolol—Urinary tract disorder—Methotrexate—breast cancer	0.000132	0.000353	CcSEcCtD
Esmolol—Oedema—Docetaxel—breast cancer	0.000132	0.000352	CcSEcCtD
Esmolol—Pruritus—Gemcitabine—breast cancer	0.000131	0.000351	CcSEcCtD
Esmolol—Nausea—Thiotepa—breast cancer	0.000131	0.00035	CcSEcCtD
Esmolol—Urethral disorder—Methotrexate—breast cancer	0.000131	0.00035	CcSEcCtD
Esmolol—Ibuprofen—PTGS2—breast cancer	0.00013	0.0161	CrCbGaD
Esmolol—Dry mouth—Capecitabine—breast cancer	0.00013	0.000348	CcSEcCtD
Esmolol—Shock—Docetaxel—breast cancer	0.00013	0.000346	CcSEcCtD
Esmolol—Nervous system disorder—Docetaxel—breast cancer	0.000129	0.000345	CcSEcCtD
Esmolol—Pruritus—Fluorouracil—breast cancer	0.000129	0.000345	CcSEcCtD
Esmolol—Drowsiness—Doxorubicin—breast cancer	0.000129	0.000345	CcSEcCtD
Esmolol—Visual impairment—Methotrexate—breast cancer	0.000129	0.000344	CcSEcCtD
Esmolol—Confusional state—Capecitabine—breast cancer	0.000129	0.000344	CcSEcCtD
Esmolol—Feeling abnormal—Paclitaxel—breast cancer	0.000128	0.000342	CcSEcCtD
Esmolol—Skin disorder—Docetaxel—breast cancer	0.000128	0.000342	CcSEcCtD
Esmolol—Oedema—Capecitabine—breast cancer	0.000128	0.000341	CcSEcCtD
Esmolol—Bradycardia—Epirubicin—breast cancer	0.000127	0.00034	CcSEcCtD
Esmolol—Neuropathy peripheral—Doxorubicin—breast cancer	0.000126	0.000338	CcSEcCtD
Esmolol—Dizziness—Irinotecan—breast cancer	0.000126	0.000337	CcSEcCtD
Esmolol—Anorexia—Docetaxel—breast cancer	0.000126	0.000336	CcSEcCtD
Esmolol—Shock—Capecitabine—breast cancer	0.000126	0.000335	CcSEcCtD
Esmolol—Rhinitis—Epirubicin—breast cancer	0.000125	0.000335	CcSEcCtD
Esmolol—Nervous system disorder—Capecitabine—breast cancer	0.000125	0.000334	CcSEcCtD
Esmolol—Pharyngitis—Epirubicin—breast cancer	0.000124	0.000332	CcSEcCtD
Esmolol—Cardiac disorder—Methotrexate—breast cancer	0.000124	0.000332	CcSEcCtD
Esmolol—Skin disorder—Capecitabine—breast cancer	0.000124	0.000331	CcSEcCtD
Esmolol—Urinary tract disorder—Epirubicin—breast cancer	0.000124	0.00033	CcSEcCtD
Esmolol—Urticaria—Paclitaxel—breast cancer	0.000124	0.00033	CcSEcCtD
Esmolol—Hyperhidrosis—Capecitabine—breast cancer	0.000123	0.00033	CcSEcCtD
Esmolol—Hypotension—Docetaxel—breast cancer	0.000123	0.000329	CcSEcCtD
Esmolol—Body temperature increased—Paclitaxel—breast cancer	0.000123	0.000328	CcSEcCtD
Esmolol—Urethral disorder—Epirubicin—breast cancer	0.000123	0.000328	CcSEcCtD
Esmolol—Anorexia—Capecitabine—breast cancer	0.000122	0.000325	CcSEcCtD
Esmolol—Angiopathy—Methotrexate—breast cancer	0.000121	0.000324	CcSEcCtD
Esmolol—Vomiting—Irinotecan—breast cancer	0.000121	0.000324	CcSEcCtD
Esmolol—Vomiting—Mitoxantrone—breast cancer	0.000121	0.000324	CcSEcCtD
Esmolol—Dizziness—Fluorouracil—breast cancer	0.000121	0.000323	CcSEcCtD
Esmolol—Visual impairment—Epirubicin—breast cancer	0.000121	0.000322	CcSEcCtD
Esmolol—Chills—Methotrexate—breast cancer	0.00012	0.000321	CcSEcCtD
Esmolol—Headache—Mitoxantrone—breast cancer	0.000119	0.000319	CcSEcCtD
Esmolol—Headache—Irinotecan—breast cancer	0.000119	0.000319	CcSEcCtD
Esmolol—Hypotension—Capecitabine—breast cancer	0.000119	0.000319	CcSEcCtD
Esmolol—Paraesthesia—Docetaxel—breast cancer	0.000118	0.000316	CcSEcCtD
Esmolol—Vomiting—Gemcitabine—breast cancer	0.000118	0.000316	CcSEcCtD
Esmolol—Bradycardia—Doxorubicin—breast cancer	0.000118	0.000315	CcSEcCtD
Esmolol—Dyspnoea—Docetaxel—breast cancer	0.000118	0.000314	CcSEcCtD
Esmolol—Propranolol—CYP3A4—breast cancer	0.000117	0.0145	CrCbGaD
Esmolol—Somnolence—Docetaxel—breast cancer	0.000117	0.000313	CcSEcCtD
Esmolol—Mental disorder—Methotrexate—breast cancer	0.000117	0.000313	CcSEcCtD
Esmolol—Erythema—Methotrexate—breast cancer	0.000116	0.000311	CcSEcCtD
Esmolol—Headache—Gemcitabine—breast cancer	0.000116	0.000311	CcSEcCtD
Esmolol—Ibuprofen—ALB—breast cancer	0.000116	0.0143	CrCbGaD
Esmolol—Flushing—Epirubicin—breast cancer	0.000116	0.00031	CcSEcCtD
Esmolol—Cardiac disorder—Epirubicin—breast cancer	0.000116	0.00031	CcSEcCtD
Esmolol—Vomiting—Fluorouracil—breast cancer	0.000116	0.00031	CcSEcCtD
Esmolol—Rhinitis—Doxorubicin—breast cancer	0.000116	0.00031	CcSEcCtD
Esmolol—Dyspepsia—Docetaxel—breast cancer	0.000116	0.00031	CcSEcCtD
Esmolol—Pharyngitis—Doxorubicin—breast cancer	0.000115	0.000307	CcSEcCtD
Esmolol—Paraesthesia—Capecitabine—breast cancer	0.000115	0.000306	CcSEcCtD
Esmolol—Decreased appetite—Docetaxel—breast cancer	0.000115	0.000306	CcSEcCtD
Esmolol—Headache—Fluorouracil—breast cancer	0.000114	0.000306	CcSEcCtD
Esmolol—Urinary tract disorder—Doxorubicin—breast cancer	0.000114	0.000306	CcSEcCtD
Esmolol—Dysgeusia—Methotrexate—breast cancer	0.000114	0.000305	CcSEcCtD
Esmolol—Gastrointestinal disorder—Docetaxel—breast cancer	0.000114	0.000304	CcSEcCtD
Esmolol—Dyspnoea—Capecitabine—breast cancer	0.000114	0.000304	CcSEcCtD
Esmolol—Fatigue—Docetaxel—breast cancer	0.000114	0.000304	CcSEcCtD
Esmolol—Angiopathy—Epirubicin—breast cancer	0.000114	0.000303	CcSEcCtD
Esmolol—Urethral disorder—Doxorubicin—breast cancer	0.000114	0.000303	CcSEcCtD
Esmolol—Nausea—Mitoxantrone—breast cancer	0.000113	0.000303	CcSEcCtD
Esmolol—Nausea—Irinotecan—breast cancer	0.000113	0.000303	CcSEcCtD
Esmolol—Pain—Docetaxel—breast cancer	0.000113	0.000301	CcSEcCtD
Esmolol—Constipation—Docetaxel—breast cancer	0.000113	0.000301	CcSEcCtD
Esmolol—Dyspepsia—Capecitabine—breast cancer	0.000112	0.0003	CcSEcCtD
Esmolol—Chills—Epirubicin—breast cancer	0.000112	0.0003	CcSEcCtD
Esmolol—Visual impairment—Doxorubicin—breast cancer	0.000112	0.000298	CcSEcCtD
Esmolol—Asthenia—Paclitaxel—breast cancer	0.000112	0.000298	CcSEcCtD
Esmolol—Decreased appetite—Capecitabine—breast cancer	0.000111	0.000296	CcSEcCtD
Esmolol—Ibuprofen—ABCB1—breast cancer	0.000111	0.0137	CrCbGaD
Esmolol—Nausea—Gemcitabine—breast cancer	0.00011	0.000295	CcSEcCtD
Esmolol—Gastrointestinal disorder—Capecitabine—breast cancer	0.00011	0.000294	CcSEcCtD
Esmolol—Fatigue—Capecitabine—breast cancer	0.00011	0.000294	CcSEcCtD
Esmolol—Pruritus—Paclitaxel—breast cancer	0.00011	0.000294	CcSEcCtD
Esmolol—Mental disorder—Epirubicin—breast cancer	0.00011	0.000293	CcSEcCtD
Esmolol—Constipation—Capecitabine—breast cancer	0.000109	0.000292	CcSEcCtD
Esmolol—Pain—Capecitabine—breast cancer	0.000109	0.000292	CcSEcCtD
Esmolol—Erythema—Epirubicin—breast cancer	0.000109	0.000291	CcSEcCtD
Esmolol—Feeling abnormal—Docetaxel—breast cancer	0.000109	0.00029	CcSEcCtD
Esmolol—Nausea—Fluorouracil—breast cancer	0.000109	0.00029	CcSEcCtD
Esmolol—Flushing—Doxorubicin—breast cancer	0.000107	0.000287	CcSEcCtD
Esmolol—Cardiac disorder—Doxorubicin—breast cancer	0.000107	0.000287	CcSEcCtD
Esmolol—Dysgeusia—Epirubicin—breast cancer	0.000107	0.000285	CcSEcCtD
Esmolol—Feeling abnormal—Capecitabine—breast cancer	0.000105	0.000281	CcSEcCtD
Esmolol—Angiopathy—Doxorubicin—breast cancer	0.000105	0.000281	CcSEcCtD
Esmolol—Body temperature increased—Docetaxel—breast cancer	0.000104	0.000278	CcSEcCtD
Esmolol—Chills—Doxorubicin—breast cancer	0.000104	0.000278	CcSEcCtD
Esmolol—Dizziness—Paclitaxel—breast cancer	0.000103	0.000275	CcSEcCtD
Esmolol—Mental disorder—Doxorubicin—breast cancer	0.000101	0.000271	CcSEcCtD
Esmolol—Urticaria—Capecitabine—breast cancer	0.000101	0.000271	CcSEcCtD
Esmolol—Body temperature increased—Capecitabine—breast cancer	0.000101	0.00027	CcSEcCtD
Esmolol—Convulsion—Methotrexate—breast cancer	0.000101	0.000269	CcSEcCtD
Esmolol—Erythema—Doxorubicin—breast cancer	0.000101	0.000269	CcSEcCtD
Esmolol—Agitation—Epirubicin—breast cancer	0.0001	0.000267	CcSEcCtD
Esmolol—Chest pain—Methotrexate—breast cancer	9.91e-05	0.000265	CcSEcCtD
Esmolol—Vomiting—Paclitaxel—breast cancer	9.89e-05	0.000264	CcSEcCtD
Esmolol—Dysgeusia—Doxorubicin—breast cancer	9.87e-05	0.000264	CcSEcCtD
Esmolol—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—breast cancer	9.84e-05	0.000263	CcSEcCtD
Esmolol—Syncope—Epirubicin—breast cancer	9.77e-05	0.000261	CcSEcCtD
Esmolol—Propranolol—ABCB1—breast cancer	9.77e-05	0.012	CrCbGaD
Esmolol—Headache—Paclitaxel—breast cancer	9.74e-05	0.00026	CcSEcCtD
Esmolol—Confusional state—Methotrexate—breast cancer	9.58e-05	0.000256	CcSEcCtD
Esmolol—Loss of consciousness—Epirubicin—breast cancer	9.58e-05	0.000256	CcSEcCtD
Esmolol—Asthenia—Docetaxel—breast cancer	9.46e-05	0.000253	CcSEcCtD
Esmolol—Convulsion—Epirubicin—breast cancer	9.44e-05	0.000252	CcSEcCtD
Esmolol—Pruritus—Docetaxel—breast cancer	9.33e-05	0.000249	CcSEcCtD
Esmolol—Nervous system disorder—Methotrexate—breast cancer	9.32e-05	0.000249	CcSEcCtD
Esmolol—Chest pain—Epirubicin—breast cancer	9.28e-05	0.000248	CcSEcCtD
Esmolol—Agitation—Doxorubicin—breast cancer	9.27e-05	0.000247	CcSEcCtD
Esmolol—Anxiety—Epirubicin—breast cancer	9.24e-05	0.000247	CcSEcCtD
Esmolol—Nausea—Paclitaxel—breast cancer	9.24e-05	0.000247	CcSEcCtD
Esmolol—Skin disorder—Methotrexate—breast cancer	9.23e-05	0.000247	CcSEcCtD
Esmolol—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—breast cancer	9.21e-05	0.000246	CcSEcCtD
Esmolol—Hyperhidrosis—Methotrexate—breast cancer	9.19e-05	0.000245	CcSEcCtD
Esmolol—Asthenia—Capecitabine—breast cancer	9.16e-05	0.000245	CcSEcCtD
Esmolol—Dry mouth—Epirubicin—breast cancer	9.07e-05	0.000242	CcSEcCtD
Esmolol—Anorexia—Methotrexate—breast cancer	9.06e-05	0.000242	CcSEcCtD
Esmolol—Syncope—Doxorubicin—breast cancer	9.04e-05	0.000242	CcSEcCtD
Esmolol—Pruritus—Capecitabine—breast cancer	9.03e-05	0.000241	CcSEcCtD
Esmolol—Confusional state—Epirubicin—breast cancer	8.97e-05	0.00024	CcSEcCtD
Esmolol—Oedema—Epirubicin—breast cancer	8.89e-05	0.000238	CcSEcCtD
Esmolol—Hypotension—Methotrexate—breast cancer	8.88e-05	0.000237	CcSEcCtD
Esmolol—Loss of consciousness—Doxorubicin—breast cancer	8.86e-05	0.000237	CcSEcCtD
Esmolol—Shock—Epirubicin—breast cancer	8.75e-05	0.000234	CcSEcCtD
Esmolol—Convulsion—Doxorubicin—breast cancer	8.74e-05	0.000233	CcSEcCtD
Esmolol—Nervous system disorder—Epirubicin—breast cancer	8.72e-05	0.000233	CcSEcCtD
Esmolol—Dizziness—Docetaxel—breast cancer	8.72e-05	0.000233	CcSEcCtD
Esmolol—Skin disorder—Epirubicin—breast cancer	8.64e-05	0.000231	CcSEcCtD
Esmolol—Hyperhidrosis—Epirubicin—breast cancer	8.6e-05	0.00023	CcSEcCtD
Esmolol—Chest pain—Doxorubicin—breast cancer	8.58e-05	0.000229	CcSEcCtD
Esmolol—Anxiety—Doxorubicin—breast cancer	8.55e-05	0.000228	CcSEcCtD
Esmolol—Paraesthesia—Methotrexate—breast cancer	8.53e-05	0.000228	CcSEcCtD
Esmolol—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—breast cancer	8.52e-05	0.000228	CcSEcCtD
Esmolol—Anorexia—Epirubicin—breast cancer	8.48e-05	0.000226	CcSEcCtD
Esmolol—Dyspnoea—Methotrexate—breast cancer	8.47e-05	0.000226	CcSEcCtD
Esmolol—Somnolence—Methotrexate—breast cancer	8.45e-05	0.000226	CcSEcCtD
Esmolol—Dizziness—Capecitabine—breast cancer	8.44e-05	0.000225	CcSEcCtD
Esmolol—Dry mouth—Doxorubicin—breast cancer	8.39e-05	0.000224	CcSEcCtD
Esmolol—Vomiting—Docetaxel—breast cancer	8.38e-05	0.000224	CcSEcCtD
Esmolol—Dyspepsia—Methotrexate—breast cancer	8.36e-05	0.000223	CcSEcCtD
Esmolol—Hypotension—Epirubicin—breast cancer	8.31e-05	0.000222	CcSEcCtD
Esmolol—Confusional state—Doxorubicin—breast cancer	8.3e-05	0.000222	CcSEcCtD
Esmolol—Decreased appetite—Methotrexate—breast cancer	8.26e-05	0.000221	CcSEcCtD
Esmolol—Headache—Docetaxel—breast cancer	8.26e-05	0.000221	CcSEcCtD
Esmolol—Oedema—Doxorubicin—breast cancer	8.23e-05	0.00022	CcSEcCtD
Esmolol—Gastrointestinal disorder—Methotrexate—breast cancer	8.2e-05	0.000219	CcSEcCtD
Esmolol—Fatigue—Methotrexate—breast cancer	8.19e-05	0.000219	CcSEcCtD
Esmolol—Pain—Methotrexate—breast cancer	8.13e-05	0.000217	CcSEcCtD
Esmolol—Vomiting—Capecitabine—breast cancer	8.12e-05	0.000217	CcSEcCtD
Esmolol—Shock—Doxorubicin—breast cancer	8.1e-05	0.000216	CcSEcCtD
Esmolol—Nervous system disorder—Doxorubicin—breast cancer	8.07e-05	0.000216	CcSEcCtD
Esmolol—Headache—Capecitabine—breast cancer	8e-05	0.000214	CcSEcCtD
Esmolol—Skin disorder—Doxorubicin—breast cancer	7.99e-05	0.000213	CcSEcCtD
Esmolol—Paraesthesia—Epirubicin—breast cancer	7.99e-05	0.000213	CcSEcCtD
Esmolol—Hyperhidrosis—Doxorubicin—breast cancer	7.95e-05	0.000212	CcSEcCtD
Esmolol—Dyspnoea—Epirubicin—breast cancer	7.93e-05	0.000212	CcSEcCtD
Esmolol—Somnolence—Epirubicin—breast cancer	7.91e-05	0.000211	CcSEcCtD
Esmolol—Anorexia—Doxorubicin—breast cancer	7.84e-05	0.00021	CcSEcCtD
Esmolol—Nausea—Docetaxel—breast cancer	7.83e-05	0.000209	CcSEcCtD
Esmolol—Feeling abnormal—Methotrexate—breast cancer	7.83e-05	0.000209	CcSEcCtD
Esmolol—Dyspepsia—Epirubicin—breast cancer	7.83e-05	0.000209	CcSEcCtD
Esmolol—Decreased appetite—Epirubicin—breast cancer	7.73e-05	0.000206	CcSEcCtD
Esmolol—Hypotension—Doxorubicin—breast cancer	7.69e-05	0.000205	CcSEcCtD
Esmolol—Gastrointestinal disorder—Epirubicin—breast cancer	7.68e-05	0.000205	CcSEcCtD
Esmolol—Fatigue—Epirubicin—breast cancer	7.67e-05	0.000205	CcSEcCtD
Esmolol—Pain—Epirubicin—breast cancer	7.6e-05	0.000203	CcSEcCtD
Esmolol—Constipation—Epirubicin—breast cancer	7.6e-05	0.000203	CcSEcCtD
Esmolol—Nausea—Capecitabine—breast cancer	7.58e-05	0.000203	CcSEcCtD
Esmolol—Urticaria—Methotrexate—breast cancer	7.55e-05	0.000202	CcSEcCtD
Esmolol—Body temperature increased—Methotrexate—breast cancer	7.51e-05	0.000201	CcSEcCtD
Esmolol—Paraesthesia—Doxorubicin—breast cancer	7.39e-05	0.000197	CcSEcCtD
Esmolol—Dyspnoea—Doxorubicin—breast cancer	7.34e-05	0.000196	CcSEcCtD
Esmolol—Feeling abnormal—Epirubicin—breast cancer	7.33e-05	0.000196	CcSEcCtD
Esmolol—Somnolence—Doxorubicin—breast cancer	7.31e-05	0.000195	CcSEcCtD
Esmolol—Dyspepsia—Doxorubicin—breast cancer	7.24e-05	0.000193	CcSEcCtD
Esmolol—Decreased appetite—Doxorubicin—breast cancer	7.15e-05	0.000191	CcSEcCtD
Esmolol—Gastrointestinal disorder—Doxorubicin—breast cancer	7.1e-05	0.00019	CcSEcCtD
Esmolol—Fatigue—Doxorubicin—breast cancer	7.09e-05	0.000189	CcSEcCtD
Esmolol—Urticaria—Epirubicin—breast cancer	7.06e-05	0.000189	CcSEcCtD
Esmolol—Constipation—Doxorubicin—breast cancer	7.04e-05	0.000188	CcSEcCtD
Esmolol—Pain—Doxorubicin—breast cancer	7.04e-05	0.000188	CcSEcCtD
Esmolol—Body temperature increased—Epirubicin—breast cancer	7.03e-05	0.000188	CcSEcCtD
Esmolol—Asthenia—Methotrexate—breast cancer	6.82e-05	0.000182	CcSEcCtD
Esmolol—Feeling abnormal—Doxorubicin—breast cancer	6.78e-05	0.000181	CcSEcCtD
Esmolol—Pruritus—Methotrexate—breast cancer	6.72e-05	0.00018	CcSEcCtD
Esmolol—Urticaria—Doxorubicin—breast cancer	6.54e-05	0.000175	CcSEcCtD
Esmolol—Body temperature increased—Doxorubicin—breast cancer	6.5e-05	0.000174	CcSEcCtD
Esmolol—Asthenia—Epirubicin—breast cancer	6.38e-05	0.00017	CcSEcCtD
Esmolol—Pruritus—Epirubicin—breast cancer	6.29e-05	0.000168	CcSEcCtD
Esmolol—Dizziness—Methotrexate—breast cancer	6.28e-05	0.000168	CcSEcCtD
Esmolol—Vomiting—Methotrexate—breast cancer	6.04e-05	0.000161	CcSEcCtD
Esmolol—Headache—Methotrexate—breast cancer	5.95e-05	0.000159	CcSEcCtD
Esmolol—Asthenia—Doxorubicin—breast cancer	5.9e-05	0.000158	CcSEcCtD
Esmolol—Dizziness—Epirubicin—breast cancer	5.88e-05	0.000157	CcSEcCtD
Esmolol—Pruritus—Doxorubicin—breast cancer	5.82e-05	0.000155	CcSEcCtD
Esmolol—Vomiting—Epirubicin—breast cancer	5.65e-05	0.000151	CcSEcCtD
Esmolol—Nausea—Methotrexate—breast cancer	5.64e-05	0.000151	CcSEcCtD
Esmolol—Headache—Epirubicin—breast cancer	5.57e-05	0.000149	CcSEcCtD
Esmolol—Dizziness—Doxorubicin—breast cancer	5.44e-05	0.000145	CcSEcCtD
Esmolol—Nausea—Epirubicin—breast cancer	5.28e-05	0.000141	CcSEcCtD
Esmolol—Vomiting—Doxorubicin—breast cancer	5.23e-05	0.00014	CcSEcCtD
Esmolol—Headache—Doxorubicin—breast cancer	5.15e-05	0.000138	CcSEcCtD
Esmolol—Nausea—Doxorubicin—breast cancer	4.89e-05	0.000131	CcSEcCtD
Esmolol—ADRB2—Signaling Pathways—VEGFC—breast cancer	1.53e-05	0.000729	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—WNT1—breast cancer	1.52e-05	0.000723	CbGpPWpGaD
Esmolol—ADRB1—Signaling by GPCR—PLA2G4A—breast cancer	1.51e-05	0.000721	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—JAG2—breast cancer	1.51e-05	0.000718	CbGpPWpGaD
Esmolol—ADRB1—Signaling by GPCR—CSF2—breast cancer	1.5e-05	0.000713	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—WNT1—breast cancer	1.48e-05	0.000707	CbGpPWpGaD
Esmolol—ADRB2—Signaling by GPCR—PLA2G4A—breast cancer	1.48e-05	0.000706	CbGpPWpGaD
Esmolol—ADRB2—Signaling by GPCR—CSF2—breast cancer	1.46e-05	0.000698	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—NOTCH4—breast cancer	1.44e-05	0.000685	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—GZMB—breast cancer	1.43e-05	0.000681	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—NOTCH4—breast cancer	1.41e-05	0.00067	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—GZMB—breast cancer	1.4e-05	0.000666	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—AGTR2—breast cancer	1.39e-05	0.000661	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—CXCL2—breast cancer	1.39e-05	0.000661	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—PTHLH—breast cancer	1.37e-05	0.000654	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—BMP2—breast cancer	1.37e-05	0.000654	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—AGTR2—breast cancer	1.36e-05	0.000647	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—CXCL2—breast cancer	1.36e-05	0.000647	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—BMP2—breast cancer	1.34e-05	0.00064	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—PTHLH—breast cancer	1.34e-05	0.00064	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—EDNRB—breast cancer	1.33e-05	0.000633	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—PGR—breast cancer	1.32e-05	0.000627	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—THBS1—breast cancer	1.31e-05	0.000624	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—EDNRB—breast cancer	1.3e-05	0.000619	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—PGR—breast cancer	1.29e-05	0.000613	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—THBS1—breast cancer	1.28e-05	0.00061	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—FLT1—breast cancer	1.25e-05	0.000595	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—FGF3—breast cancer	1.24e-05	0.000593	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—SQSTM1—breast cancer	1.24e-05	0.000593	CbGpPWpGaD
Esmolol—ADRB1—GPCR downstream signaling—PIK3CG—breast cancer	1.24e-05	0.00059	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—JAG1—breast cancer	1.23e-05	0.000585	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—PARP1—breast cancer	1.22e-05	0.000583	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—NOTCH3—breast cancer	1.22e-05	0.000583	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—FLT1—breast cancer	1.22e-05	0.000582	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—FGF3—breast cancer	1.22e-05	0.00058	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—SQSTM1—breast cancer	1.22e-05	0.00058	CbGpPWpGaD
Esmolol—ADRB2—GPCR downstream signaling—PIK3CG—breast cancer	1.21e-05	0.000577	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—CALCA—breast cancer	1.21e-05	0.000576	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—JAG1—breast cancer	1.2e-05	0.000572	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—NOTCH3—breast cancer	1.2e-05	0.00057	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—PARP1—breast cancer	1.2e-05	0.00057	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—RPS6—breast cancer	1.19e-05	0.000569	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—FGF4—breast cancer	1.18e-05	0.000564	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—CALCA—breast cancer	1.18e-05	0.000563	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—CXCR4—breast cancer	1.18e-05	0.000562	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—CXCL12—breast cancer	1.18e-05	0.000562	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—RPS6—breast cancer	1.17e-05	0.000556	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—FGF4—breast cancer	1.16e-05	0.000552	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—PAK1—breast cancer	1.16e-05	0.000552	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—CXCL12—breast cancer	1.15e-05	0.00055	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—CXCR4—breast cancer	1.15e-05	0.00055	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—TCF7L2—breast cancer	1.14e-05	0.000542	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—PAK1—breast cancer	1.13e-05	0.00054	CbGpPWpGaD
Esmolol—ADRB1—GPCR downstream signaling—AKT2—breast cancer	1.13e-05	0.00054	CbGpPWpGaD
Esmolol—ADRB1—Signaling by GPCR—PIK3CG—breast cancer	1.12e-05	0.000536	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—TCF7L2—breast cancer	1.11e-05	0.00053	CbGpPWpGaD
Esmolol—ADRB2—GPCR downstream signaling—AKT2—breast cancer	1.11e-05	0.000528	CbGpPWpGaD
Esmolol—ADRB2—Signaling by GPCR—PIK3CG—breast cancer	1.1e-05	0.000524	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—HSP90AA1—breast cancer	1.1e-05	0.000523	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—NOTCH2—breast cancer	1.1e-05	0.000523	CbGpPWpGaD
Esmolol—ADRB1—GPCR downstream signaling—PIK3CD—breast cancer	1.09e-05	0.000518	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—HSP90AA1—breast cancer	1.07e-05	0.000511	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—NOTCH2—breast cancer	1.07e-05	0.000511	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—PRL—breast cancer	1.07e-05	0.000508	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—AGTR1—breast cancer	1.07e-05	0.000508	CbGpPWpGaD
Esmolol—ADRB2—GPCR downstream signaling—PIK3CD—breast cancer	1.06e-05	0.000507	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—STK11—breast cancer	1.05e-05	0.000501	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—ADAM10—breast cancer	1.05e-05	0.000501	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—PRL—breast cancer	1.04e-05	0.000497	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—AGTR1—breast cancer	1.04e-05	0.000497	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—PLG—breast cancer	1.04e-05	0.000496	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—STK11—breast cancer	1.03e-05	0.00049	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—ADAM10—breast cancer	1.03e-05	0.00049	CbGpPWpGaD
Esmolol—ADRB1—Signaling by GPCR—AKT2—breast cancer	1.03e-05	0.00049	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—FGF10—breast cancer	1.02e-05	0.000487	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—PLG—breast cancer	1.02e-05	0.000485	CbGpPWpGaD
Esmolol—ADRB2—Signaling by GPCR—AKT2—breast cancer	1.01e-05	0.000479	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—FGF10—breast cancer	1e-05	0.000477	CbGpPWpGaD
Esmolol—ADRB1—Signaling by GPCR—PIK3CD—breast cancer	9.88e-06	0.000471	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—PDGFA—breast cancer	9.87e-06	0.00047	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—TGFBR2—breast cancer	9.73e-06	0.000464	CbGpPWpGaD
Esmolol—ADRB2—Signaling by GPCR—PIK3CD—breast cancer	9.67e-06	0.000461	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—PDGFA—breast cancer	9.66e-06	0.00046	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—ITPR1—breast cancer	9.57e-06	0.000456	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—TGFBR2—breast cancer	9.52e-06	0.000454	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—MMP3—breast cancer	9.51e-06	0.000453	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—ERBB4—breast cancer	9.51e-06	0.000453	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—STAT5A—breast cancer	9.51e-06	0.000453	CbGpPWpGaD
Esmolol—ADRB1—GPCR downstream signaling—PIK3CB—breast cancer	9.48e-06	0.000452	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—ITPR1—breast cancer	9.37e-06	0.000446	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—MMP3—breast cancer	9.3e-06	0.000443	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—ERBB4—breast cancer	9.3e-06	0.000443	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—STAT5A—breast cancer	9.3e-06	0.000443	CbGpPWpGaD
Esmolol—ADRB2—GPCR downstream signaling—PIK3CB—breast cancer	9.28e-06	0.000442	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—SMAD4—breast cancer	9.21e-06	0.000439	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—IGF1R—breast cancer	9.15e-06	0.000436	CbGpPWpGaD
Esmolol—ADRB1—GPCR downstream signaling—CXCL8—breast cancer	9.11e-06	0.000434	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—SMAD4—breast cancer	9.01e-06	0.000429	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—HES1—breast cancer	8.99e-06	0.000429	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—IGF1R—breast cancer	8.95e-06	0.000427	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—PLA2G4A—breast cancer	8.94e-06	0.000426	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—NCOR1—breast cancer	8.94e-06	0.000426	CbGpPWpGaD
Esmolol—ADRB2—GPCR downstream signaling—CXCL8—breast cancer	8.91e-06	0.000425	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—CSF2—breast cancer	8.84e-06	0.000421	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—FGF1—breast cancer	8.84e-06	0.000421	CbGpPWpGaD
Esmolol—ADRB1—Signaling by GPCR—RAF1—breast cancer	8.82e-06	0.00042	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—HES1—breast cancer	8.8e-06	0.000419	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—NRG1—breast cancer	8.78e-06	0.000418	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—PLA2G4A—breast cancer	8.75e-06	0.000417	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—NCOR1—breast cancer	8.75e-06	0.000417	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—H2AFX—breast cancer	8.71e-06	0.000415	CbGpPWpGaD
Esmolol—ADRB1—GPCR downstream signaling—IL2—breast cancer	8.71e-06	0.000415	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—E2F1—breast cancer	8.65e-06	0.000412	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—CSF2—breast cancer	8.65e-06	0.000412	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—FGF1—breast cancer	8.65e-06	0.000412	CbGpPWpGaD
Esmolol—ADRB2—Signaling by GPCR—RAF1—breast cancer	8.63e-06	0.000411	CbGpPWpGaD
Esmolol—ADRB1—Signaling by GPCR—PIK3CB—breast cancer	8.61e-06	0.00041	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—NRG1—breast cancer	8.59e-06	0.000409	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—H2AFX—breast cancer	8.52e-06	0.000406	CbGpPWpGaD
Esmolol—ADRB2—GPCR downstream signaling—IL2—breast cancer	8.52e-06	0.000406	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—E2F1—breast cancer	8.46e-06	0.000403	CbGpPWpGaD
Esmolol—ADRB2—Signaling by GPCR—PIK3CB—breast cancer	8.42e-06	0.000401	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—SPP1—breast cancer	8.31e-06	0.000396	CbGpPWpGaD
Esmolol—ADRB1—Signaling by GPCR—CXCL8—breast cancer	8.28e-06	0.000394	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—ERBB3—breast cancer	8.22e-06	0.000392	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—FGFR2—breast cancer	8.21e-06	0.000391	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—SPP1—breast cancer	8.13e-06	0.000388	CbGpPWpGaD
Esmolol—ADRB2—Signaling by GPCR—CXCL8—breast cancer	8.1e-06	0.000386	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—ERBB3—breast cancer	8.04e-06	0.000383	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—FGFR2—breast cancer	8.03e-06	0.000383	CbGpPWpGaD
Esmolol—ADRB1—Signaling by GPCR—IL2—breast cancer	7.91e-06	0.000377	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—TERT—breast cancer	7.88e-06	0.000376	CbGpPWpGaD
Esmolol—ADRB2—Signaling by GPCR—IL2—breast cancer	7.74e-06	0.000369	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—TERT—breast cancer	7.71e-06	0.000367	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—FGFR1—breast cancer	7.65e-06	0.000365	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—HIF1A—breast cancer	7.54e-06	0.000359	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—FGFR1—breast cancer	7.48e-06	0.000357	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—HIF1A—breast cancer	7.37e-06	0.000351	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—LEP—breast cancer	7.36e-06	0.000351	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—CAV1—breast cancer	7.29e-06	0.000347	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—KDR—breast cancer	7.21e-06	0.000343	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—LEP—breast cancer	7.2e-06	0.000343	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—CAV1—breast cancer	7.13e-06	0.00034	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—KDR—breast cancer	7.05e-06	0.000336	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—ESR1—breast cancer	7.02e-06	0.000335	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—FN1—breast cancer	6.94e-06	0.000331	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—ESR1—breast cancer	6.87e-06	0.000327	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—NFKBIA—breast cancer	6.86e-06	0.000327	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—NOTCH1—breast cancer	6.79e-06	0.000324	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—FN1—breast cancer	6.79e-06	0.000323	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—NFKBIA—breast cancer	6.71e-06	0.00032	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—NOTCH1—breast cancer	6.64e-06	0.000316	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—PIK3CG—breast cancer	6.64e-06	0.000316	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—KIT—breast cancer	6.64e-06	0.000316	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—APC—breast cancer	6.64e-06	0.000316	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—EGF—breast cancer	6.56e-06	0.000313	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—PIK3CG—breast cancer	6.49e-06	0.00031	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—APC—breast cancer	6.49e-06	0.00031	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—KIT—breast cancer	6.49e-06	0.00031	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—EGF—breast cancer	6.42e-06	0.000306	CbGpPWpGaD
Esmolol—ADRB1—Signaling by GPCR—MAPK3—breast cancer	6.36e-06	0.000303	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—BRAF—breast cancer	6.24e-06	0.000297	CbGpPWpGaD
Esmolol—ADRB2—Signaling by GPCR—MAPK3—breast cancer	6.22e-06	0.000296	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—BRAF—breast cancer	6.1e-06	0.000291	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—IGF1—breast cancer	6.08e-06	0.00029	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—AKT2—breast cancer	6.07e-06	0.000289	CbGpPWpGaD
Esmolol—ADRB1—Signaling by GPCR—EGFR—breast cancer	6.05e-06	0.000288	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—IGF1—breast cancer	5.95e-06	0.000283	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—AKT2—breast cancer	5.94e-06	0.000283	CbGpPWpGaD
Esmolol—ADRB2—Signaling by GPCR—EGFR—breast cancer	5.92e-06	0.000282	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—PIK3CD—breast cancer	5.84e-06	0.000278	CbGpPWpGaD
Esmolol—ADRB1—GPCR downstream signaling—PIK3CA—breast cancer	5.78e-06	0.000276	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—SERPINE1—breast cancer	5.77e-06	0.000275	CbGpPWpGaD
Esmolol—ADRB1—Signaling by GPCR—KRAS—breast cancer	5.71e-06	0.000272	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—PIK3CD—breast cancer	5.71e-06	0.000272	CbGpPWpGaD
Esmolol—ADRB2—GPCR downstream signaling—PIK3CA—breast cancer	5.66e-06	0.00027	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—SERPINE1—breast cancer	5.65e-06	0.000269	CbGpPWpGaD
Esmolol—ADRB2—Signaling by GPCR—KRAS—breast cancer	5.59e-06	0.000266	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—NOS3—breast cancer	5.51e-06	0.000263	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—NOS3—breast cancer	5.39e-06	0.000257	CbGpPWpGaD
Esmolol—ADRB1—Signaling by GPCR—PIK3CA—breast cancer	5.25e-06	0.00025	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—MDM2—breast cancer	5.23e-06	0.000249	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—RAF1—breast cancer	5.21e-06	0.000248	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—RELA—breast cancer	5.19e-06	0.000247	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—ERBB2—breast cancer	5.16e-06	0.000246	CbGpPWpGaD
Esmolol—ADRB2—Signaling by GPCR—PIK3CA—breast cancer	5.14e-06	0.000245	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—MDM2—breast cancer	5.11e-06	0.000244	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—RAF1—breast cancer	5.1e-06	0.000243	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—PIK3CB—breast cancer	5.09e-06	0.000242	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—MTOR—breast cancer	5.09e-06	0.000242	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—RELA—breast cancer	5.07e-06	0.000242	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—ERBB2—breast cancer	5.04e-06	0.00024	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—MTOR—breast cancer	4.98e-06	0.000237	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—PIK3CB—breast cancer	4.98e-06	0.000237	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—CXCL8—breast cancer	4.89e-06	0.000233	CbGpPWpGaD
Esmolol—ADRB1—Signaling by GPCR—HRAS—breast cancer	4.86e-06	0.000231	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—CXCL8—breast cancer	4.78e-06	0.000228	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—CDKN1B—breast cancer	4.77e-06	0.000228	CbGpPWpGaD
Esmolol—ADRB2—Signaling by GPCR—HRAS—breast cancer	4.75e-06	0.000226	CbGpPWpGaD
Esmolol—ADRB1—GPCR downstream signaling—AKT1—breast cancer	4.72e-06	0.000225	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—CASP3—breast cancer	4.68e-06	0.000223	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—IL2—breast cancer	4.67e-06	0.000223	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—CDKN1B—breast cancer	4.67e-06	0.000223	CbGpPWpGaD
Esmolol—ADRB1—Signaling by GPCR—IL6—breast cancer	4.65e-06	0.000222	CbGpPWpGaD
Esmolol—ADRB2—GPCR downstream signaling—AKT1—breast cancer	4.62e-06	0.00022	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—CASP3—breast cancer	4.58e-06	0.000218	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—IL2—breast cancer	4.57e-06	0.000218	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—CCND1—breast cancer	4.55e-06	0.000217	CbGpPWpGaD
Esmolol—ADRB2—Signaling by GPCR—IL6—breast cancer	4.55e-06	0.000217	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—JUN—breast cancer	4.54e-06	0.000217	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—CTNNB1—breast cancer	4.51e-06	0.000215	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—CCND1—breast cancer	4.46e-06	0.000212	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—JUN—breast cancer	4.45e-06	0.000212	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—MMP9—breast cancer	4.42e-06	0.000211	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—CTNNB1—breast cancer	4.41e-06	0.00021	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—CDKN1A—breast cancer	4.41e-06	0.00021	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—PTEN—breast cancer	4.4e-06	0.000209	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—MMP9—breast cancer	4.33e-06	0.000206	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—CDKN1A—breast cancer	4.31e-06	0.000205	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—MAPK8—breast cancer	4.3e-06	0.000205	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—PTEN—breast cancer	4.3e-06	0.000205	CbGpPWpGaD
Esmolol—ADRB1—Signaling by GPCR—AKT1—breast cancer	4.29e-06	0.000204	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—MAPK8—breast cancer	4.21e-06	0.0002	CbGpPWpGaD
Esmolol—ADRB2—Signaling by GPCR—AKT1—breast cancer	4.2e-06	0.0002	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—SRC—breast cancer	4.08e-06	0.000194	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—SRC—breast cancer	3.99e-06	0.00019	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—VEGFA—breast cancer	3.97e-06	0.000189	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—STAT3—breast cancer	3.93e-06	0.000187	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—VEGFA—breast cancer	3.88e-06	0.000185	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—STAT3—breast cancer	3.85e-06	0.000183	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—MAPK3—breast cancer	3.76e-06	0.000179	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—MAPK3—breast cancer	3.67e-06	0.000175	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—MYC—breast cancer	3.65e-06	0.000174	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—TGFB1—breast cancer	3.64e-06	0.000174	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—MYC—breast cancer	3.57e-06	0.00017	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—EGFR—breast cancer	3.57e-06	0.00017	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—TGFB1—breast cancer	3.57e-06	0.00017	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—EGFR—breast cancer	3.5e-06	0.000167	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—KRAS—breast cancer	3.38e-06	0.000161	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—KRAS—breast cancer	3.3e-06	0.000157	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—PIK3CA—breast cancer	3.1e-06	0.000148	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—PIK3CA—breast cancer	3.03e-06	0.000145	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—TP53—breast cancer	3e-06	0.000143	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—TP53—breast cancer	2.93e-06	0.00014	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—HRAS—breast cancer	2.87e-06	0.000137	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—HRAS—breast cancer	2.81e-06	0.000134	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—IL6—breast cancer	2.75e-06	0.000131	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—IL6—breast cancer	2.69e-06	0.000128	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—AKT1—breast cancer	2.53e-06	0.000121	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—AKT1—breast cancer	2.48e-06	0.000118	CbGpPWpGaD
